GSK Proposes Creating Unit Dedicated To Vaccine Development For Disease Outbreaks

Bloomberg News: Glaxo Proposes Biopreparedness Unit for Outbreaks Like Zika
“As the Zika virus spreads and concern grows about the world’s preparedness for outbreaks, GlaxoSmithKline is proposing the creation of a unit dedicated to developing vaccines for diseases in markets offering little potential profit. The London-based company is ready to provide a facility, staff, and technology, and would welcome funding from the U.S., the U.K., the World Health Organization, and other public entities, Ripley Ballou, Glaxo’s vice president of vaccines, said in a phone interview…” (Chen, 9/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.